arrow_back Back to App

Congress Rejects FDA Regulations on Laboratory Developed Tests

The U.S. Congress has decided to disapprove new Food and Drug Administration (FDA) rules concerning medical tests developed in laboratories. This means these regulations will not take effect, potentially impacting the availability and oversight of certain diagnostic tests for citizens.
Key points
Congress invalidates FDA regulations on laboratory developed medical tests.
The disapproval means the rules will have no legal force or effect.
This may influence how diagnostic tests are developed and accessed by patients.
article Official text account_balance Process page
Expired
Citizen Poll
No votes cast
Additional Information
Print number: 118_HJRES_145
Sponsor: Rep. Finstad, Brad [R-MN-1]
Process start date: 2024-05-16
Lustra uses Artificial Intelligence. Verify details in source documents.
Summarized by: gemini-2.5-flash
Source data: api.congress.gov
AI work logs for this document launch

OFFICIAL LEGAL TITLE

Providing for congressional disapproval under chapter 8 of title 5, United States Code, of the rule submitted by the Food and Drug Administration relating to "Medical Devices; Laboratory Developed Tests".

FREQUENTLY ASKED QUESTIONS

What is the official ID of this bill?

The official print number for this legislation is 118_HJRES_145.

Which chamber initiated this legislation?

This legislation was initiated in the House of Representatives.

When did the legislative process begin?

The process officially started on 2024-05-16.

What are the main provisions?

Key points include:

  • Congress invalidates FDA regulations on laboratory developed medical tests.
  • The disapproval means the rules will have no legal force or effect.
  • This may influence how diagnostic tests are developed and accessed by patients.
What is the specific legal status?

The current status is Expired.

Where can I read the full text of this legislation?

The full official text is available at: View full text

Who is the primary sponsor?

The primary sponsor is Rep. Finstad, Brad [R-MN-1].

What is the latest detailed status?

The latest detailed status is: Referred to the Subcommittee on Health.

Is this summary verified?

Yes. This content was analyzed by AI and verified by the Lustra Judge System on 2025-12-24.

CATEGORIES

Health